A Smart + Strong Site
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:
Back to home » Top Stories » CROI 2009
CROI 2009 16th Conference on Retroviruses and Opportunistic Infections
Montréal, Canada
February 8-11, 2009

HIV Itself Is a Major Heart Disease Risk Factor

February 11, 2009

By David Evans

HIV infection itself appears to increase the thickness of the carotid artery and is therefore a significant independent risk factor for developing cardiovascular disease (CVD)—ultimately increasing the risk of a heart attack or stroke—according to a new study presented Wednesday, February 11, at the 16th Conference on Retroviruses and Opportunistic Infections (CROI) in Montreal.

Ever since researchers first noticed that protease inhibitors could significantly increase a person’s cholesterol and triglycerides, they have attempted to quantify the additional risk that people with HIV may have in developing CVD. Subsequent research over the years has suggested that some protease inhibitors and the nucleoside reverse transcriptase inhibitor abacavir (found in Ziagen, Epzicom and Trizivir) may increase a person’s CVD risk somewhat. Research also appeared to show that people with HIV were more likely than their HIV-negative peers to have heart attacks. Thus far, however, no study has adequately quantified the additional risk that the virus itself may confer.

To explore this, Carl Grunfeld, MD, from the University of California in San Francisco, and his colleagues compared the carotid artery thickness of 433 HIV-positive patients to 5,749 HIV-negative patients. The thickness of the carotid artery in the neck—called carotid intima-media thickness—can be measured using ultrasound; when found to be thicker than normal, it tends to predict the likelihood of cardiovascular events such as heart attacks.

Specifically, Grunfeld and his colleagues looked at the thickness of the artery in two spots. Previous research, focusing a segment of the artery known as the common carotid, had failed to consistently show thickening in people with HIV. Grunfeld and his team reasoned that increased thickness of the internal carotid, which is higher up and closer to the brain, would be a better indicator of inflammation that may be caused by HIV infection, due to the turbulent nature of the blood flow there.

Sure enough, Grunfeld’s team found a significant increase in thickness in the internal carotid artery in people with HIV. In fact, HIV infection alone was associated with the same amount, if not more, of thickening in the internal carotid artery that is associated with other factors such as age, smoking and diabetes. The impact was even more pronounced in HIV-positive women.

Grunfeld showed that the increases in thickness of the internal carotid artery were not as significant in the common carotid, where most previous studies had looked. He said this could explain why some previous studies had failed to find associations between HIV and artery thickening.

Grunfeld conceded in his talk that although the study’s sample size was large, he could not yet directly link increases in artery thickness to clinical events such as heart attacks. He did, however, indicate that studies in the general population consistently demonstrate that people with thicker carotid arteries have a much higher risk of CVD.

When asked what the underlying mechanism may be, he indicated it is likely a complex combination of each person’s immune system response to HIV along with the negative influence of some HIV treatments.

Scroll down to comment on this story.

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

       

More from CROI 2009

HIV/AIDS Complications

March 4, 2009
HIV and Women
February 26, 2009
HIV and the Brain: What to Watch Out For
February 25, 2009
HIV and Cancer: Prevalence and Prevention
February 23, 2009
Half of Deaths in People With HIV No Longer From AIDS
February 20, 2009
Testosterone Therapy: Good for Women Too
Lymphoma: Death Rates Still High, but Cancer May Be Predicted
February 19, 2009
Quarter of U.S. Positive Women Not Receiving Annual Pap Smears
February 18, 2009
HDL and Small HDL Particles Predict Cardio Problems in HIV
Scientists Still Seeking Clues to Abacavir Heart Attack Mystery
February 17, 2009
Smoking Cessation: Hispanics, Nicotine Patch Users Do Best
Nerve Damage Is a Common Problem in People With HIV
February 11, 2009
PIs, Abacavir and Cardiovascular Disease: What’s the Risk?
D:A:D Study: Reduce Modifiable Risk Factors to Improve Survival
HIV Itself Is a Major Heart Disease Risk Factor
February 10, 2009
Age, Diabetes & a Bigger Waist Line Tied to Cognitive Problems in HIV
February 9, 2009
Diabetes Drug Avandia Helps Reverse Lipoatrophy

HIV Transmission and Prevention

February 27, 2009
Prevention Highlights, Part 1: PrEP
Prevention Highlights, Part 2: Treatment as Prevention
February 13, 2009
Microbicides Make a Comeback
February 9, 2009
HIV Treatment Greatly Reduces, But Doesn’t Eliminate Transmission

Starting and Switching Treatment

February 12, 2009
Isentress Shows Long-Term Benefits in Treatment-Experienced Patients
Antidepressants Improve Viral Load Response to Treatment Due to Better Adherence
February 10, 2009
Start HIV Treatment Early—But When?
February 9, 2009
Kaletra-to-Isentress Switch Helps Lipids, but With Viral Rebound Risk

Experimental HIV Drugs

February 20, 2009
Antiretroviral Highlights from CROI
February 10, 2009
IL-2 Fails in Two Large Studies
February 9, 2009
GS 9350 and SPI-452: Emerging Alternatives to Norvir Boosting


[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.